PLoS ONE (Jan 2020)
Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0218494.].